Clinical Trial Update: An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Open-label extension study update for ORKA-001 in plaque psoriasis (Phase 2), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ORKA-001

Snippet

Sponsor: Oruka Therapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: RECRUITING